Top Page
Challenger
(Sydney:CGF)
Challenger (CGF) vs. iShares MSCI Australia ETF (EWA)
Challenger Business Overview & Revenue Model
Challenger Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.20B | 750.50M | 3.28B | 2.23B | -414.30M | 3.03B |
| Gross Profit | 750.50M | 750.50M | 635.90M | 652.20M | 1.36B | 1.79B |
| EBITDA | 1.07B | 1.11B | 924.70M | 970.50M | 414.30M | 1.17B |
| Net Income | 192.30M | 192.30M | 129.90M | 287.50M | 253.70M | 592.30M |
Balance Sheet | ||||||
| Total Assets | 34.95B | 34.95B | 33.41B | 30.98B | 29.74B | 29.99B |
| Cash, Cash Equivalents and Short-Term Investments | 32.39B | 32.39B | 573.20M | 593.40M | 733.10M | 989.40M |
| Total Debt | 8.27B | 8.27B | 7.13B | 5.89B | 5.85B | 6.39B |
| Total Liabilities | 31.09B | 31.09B | 29.52B | 26.81B | 25.75B | 26.17B |
| Stockholders Equity | 3.86B | 3.86B | 3.88B | 4.16B | 3.99B | 3.83B |
Cash Flow | ||||||
| Free Cash Flow | 399.40M | 399.40M | 841.80M | 1.27B | 2.48B | 2.56B |
| Operating Cash Flow | 399.60M | 399.60M | 843.70M | 1.27B | 2.49B | 2.58B |
| Investing Cash Flow | -1.18B | -1.18B | -1.94B | -1.34B | -2.12B | -865.00M |
| Financing Cash Flow | 854.70M | 854.70M | 1.08B | -35.00M | -619.80M | -1.38B |
Challenger Technical Analysis
Challenger Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | AU$6.29B | 54.73 | 67.81% | 1.45% | 28.29% | 39.39% | |
62 Neutral | AU$143.13M | 18.50 | 8.88% | ― | 21.79% | -23.00% | |
61 Neutral | AU$3.72B | 27.59 | 19.56% | 3.45% | 37.42% | 38.37% | |
60 Neutral | AU$6.48B | 33.64 | 4.84% | 3.10% | 11.78% | 47.53% | |
56 Neutral | AU$1.96B | 23.00 | 5.31% | ― | 16.78% | 22.86% | |
50 Neutral | AU$2.22B | -37.34 | -3.34% | 6.01% | 2.87% | 87.93% |
Challenger Corporate Events
Challenger Limited has announced its financial calendar for 2026, detailing key dates for half-year and full-year results, dividend announcements, and other significant events. This schedule provides stakeholders with a clear timeline for financial disclosures, which is crucial for investors and market analysts in planning and decision-making.
The most recent analyst rating on (AU:CGF) stock is a Buy with a A$10.25 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced a new distribution for its security, CAP NOTE 3-BBSW+3.60% PERP NON-CUM RED T-05-29, with a distribution amount of AUD 1.28. The payment is scheduled for February 25, 2026, following the record date of February 17, 2026. This discretionary distribution reflects Challenger’s ongoing commitment to providing returns to its investors, although it is contingent upon no payment conditions existing on the payment date.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$8.50 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced a new distribution for its Capital Notes 3, with a payment of AUD 1.46 scheduled for February 25, 2026. This discretionary distribution is subject to the absence of any payment conditions, reflecting Challenger’s ongoing commitment to providing returns to its stakeholders while maintaining flexibility in its financial operations.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$8.50 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited announced that S&P Global Ratings has upgraded the credit ratings for both Challenger Life Company Limited and Challenger Limited, reflecting the company’s market leadership in the Australian annuities market and strong retirement savings trends. The upgrade highlights Challenger’s competitive advantage in risk management and capital adequacy, which supports its ability to navigate market and credit stress.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$8.50 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited announced a change in the interests of its director, Nicolas Hamilton, who has acquired an additional 305,381 Hurdled Performance Share Rights as part of an annual remuneration review. This adjustment increases his total holdings to 1,680,858 Performance Rights and Restricted Shares under the Challenger Performance Plan, potentially impacting the company’s governance and aligning director incentives with company performance.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$8.50 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced the appointment of Damian Graham as the Group Chief Investment Officer, effective January 2026. This new role aims to integrate investment teams from Challenger Life and Funds Management, enhancing alignment of investment capabilities. Graham, with over 30 years of experience in investment management, will lead the unified investment team, leveraging his expertise in superannuation and retirement industries to drive investment excellence and support Challenger’s mission of providing financial security for better retirements.
The most recent analyst rating on (AU:CGF) stock is a Sell with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited announced the results of its Annual General Meeting held on October 30, 2025. Key resolutions passed include the adoption of the Remuneration Report for the financial year ended June 2025, approval for granting long-term performance share rights to the CEO, and the re-election of directors John Somerville and David Whittle. These resolutions reflect strong shareholder support and are expected to reinforce the company’s leadership and strategic direction.
The most recent analyst rating on (AU:CGF) stock is a Buy with a A$10.10 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has expressed strong support for APRA’s proposed capital standards for longevity products, which aim to enhance Australia’s retirement income market by reducing capital requirements and promoting innovation. These reforms are expected to improve Challenger’s financial resilience, reduce procyclicality during market stress, and drive growth in the lifetime income market, benefiting retirees and the broader community.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$9.50 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited reported a strong start to FY26 with a 4% increase in total life sales, driven by significant growth in annuity sales. The company is making strategic progress by forming partnerships with superannuation funds and launching new products, such as the ASX listed income notes, LiFTS, to meet the demand for guaranteed retirement income. Despite a decrease in funds under management, Challenger is expanding its offerings and remains well-capitalized, positioning itself for future growth amid upcoming regulatory changes that are expected to benefit the industry and retirees.
The most recent analyst rating on (AU:CGF) stock is a Buy with a A$9.60 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced the issuance of 1,548,539 performance rights as part of an employee incentive scheme. These unquoted securities are not intended to be listed on the ASX, indicating a move to reward and retain key personnel, potentially impacting the company’s operational dynamics and aligning employee interests with corporate goals.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$8.50 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced the cessation of 298,281 performance rights due to the lapse of conditional rights that were not satisfied. This development may affect the company’s capital structure and could have implications for stakeholders regarding the company’s future performance and strategic direction.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$8.50 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced changes in its shareholding structure, specifically regarding its interests and derivative exposures. The company, through its controlled entities, has a minor interest in 33,429 ordinary shares, representing 0.0048% of total shares. Recent changes include acquisitions and forfeitures of shares by the Challenger Performance Plan Trust, affecting the company’s overall shareholding and potentially its market positioning.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$8.50 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced that it has ceased to be a substantial holder in The A2 Milk Company Limited. This change in holdings reflects a strategic decision by Challenger, potentially impacting its investment portfolio and signaling a shift in its market focus. The announcement may have implications for stakeholders as it indicates a reallocation of resources or a change in investment strategy.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$8.50 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.